Hepatitis D Overview

Save information for later
Sign Up

Learn About Hepatitis D

View Main Condition: Hepatitis

What is the definition of Hepatitis D?
Hepatitis D, also known as “Delta Hepatitis,” is an infection of the liver caused by the hepatitis D virus (HDV) that causes liver inflammation and damage. Hepatitis D can only occur in individuals who are already infected with the hepatitis B virus (HBV). Hepatitis D can be acute (short-term) or become a chronic (long-term) infection. Co-infection with both the hepatitis B virus and the hepatitis D virus (superinfection) is the most severe form of chronic hepatitis and can rapidly lead to the development of hepatocellular carcinoma (liver cancer; HCC) or death. Hepatitis D is transmitted by blood or body fluids through sexual contact, the shared use of contaminated needles, or infected blood transfusions.
What are the symptoms of Hepatitis D?
Symptoms of an acute hepatitis D infection may include weakness, fatigue, lack of appetite, nausea and vomiting, right upper abdominal pain over the liver, dark urine, pale stool, and jaundice (yellowing of eyes and skin). Individuals with a chronic hepatitis D infection may have little or no symptoms for years until developing cirrhosis (scarring liver disease) when they may experience weakness, fatigue, weight loss, abdominal swelling, ankle swelling (edema), itching, and jaundice. Chronic hepatitis D infection may cause severe complications, such hepatocellular carcinoma (liver cancer) and death.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hepatitis D?
There is currently no treatment for acute hepatitis D infection. Chronic hepatitis D infection may be treated with pegylated interferon alpha for at least 48 weeks or antiviral drugs, such as entecavir. Hepatitis D infection can be prevented with the hepatitis B vaccine.
Who are the top Hepatitis D Local Doctors?
Experienced in Hepatitis D
Dr. Mamta K. Jain
Internal Medicine
Experienced in Hepatitis D
Dr. Mamta K. Jain
Internal Medicine
3115 College Park Dr, Suite 112, 
The Woodlands, TX 
 (39.1 mi)
281-836-3627
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Mamta Jain is an Internal Medicine provider in The Woodlands, Texas. Dr. Jain and is rated as an Experienced provider by MediFind in the treatment of Hepatitis D. Her top areas of expertise are Hepatitis, Hepatitis C, HIV/AIDS, and Hepatitis B. Dr. Jain is currently accepting new patients.

Experienced in Hepatitis D
Dr. Saad A. Choudhry
Internal Medicine
Experienced in Hepatitis D
Dr. Saad A. Choudhry
Internal Medicine

Lonestar Hospital Medicine Associates PA

22999 Hwy 59 N, 
Kingwood, TX 
 (54.9 mi)
281-348-8000
Languages Spoken:
English
Accepting New Patients

Saad Choudhry is an Internal Medicine provider in Kingwood, Texas. Dr. Choudhry and is rated as an Experienced provider by MediFind in the treatment of Hepatitis D. His top areas of expertise are Hepatitis, Hepatitis B, and Hepatitis D. Dr. Choudhry is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Hepatitis D
Dr. Richard R. Andrews
Family Medicine
Experienced in Hepatitis D
Dr. Richard R. Andrews
Family Medicine
6311 Fulton St, 
Houston, TX 
 (58.3 mi)
713-694-8100
Languages Spoken:
English, Japanese, Korean, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Richard Andrews is a Family Medicine provider in Houston, Texas. Dr. Andrews and is rated as an Experienced provider by MediFind in the treatment of Hepatitis D. His top areas of expertise are Hepatitis D, Hepatitis, Jaundice, and Hepatitis C. Dr. Andrews is currently accepting new patients.

View All Doctors
What are the latest Hepatitis D Clinical Trials?
A Parallel-group, Randomized, Open-label Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D.
A Parallel-group, Randomized, Open-label Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D.
Enrollment Status: Recruiting
Publish Date: February 24, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: The goal of this clinical trial is to evaluate the efficacy and safety of L47 in the treatment of chronic hepatitis D. Patients with compensated CHD who satisfy the eligibility criteria are stratified by the presence or absence of liver cirrhosis and randomized into three groups at a 1:1:1 ratio. The subjects will receive continuous L47 (2.1 mg/d and 4.2 mg/d, s.c.) treatment for 48 weeks (groups ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
Enrollment Status: Recruiting
Publish Date: February 21, 2025
Intervention Type: Drug

Summary: The main goal of this study is to collect post marketing data from patients with chronic hepatitis D virus (HDV) infection who are treated with bulevirtide to describe the long-term effects of bulevirtide treatment and evaluate the safety of participants treated with bulevirtide.

View All Clinical Trials